Revenue breakdown of Yiling Pharmaceutical by product 2022

Published by
Wenyi Zhang,
Nov 17, 2023
In 2022, Yiling Pharmaceutical made more than half of its revenue from medications treating respiratory diseases. Meanwhile, cardiovascular and cerebrovascular products remained an important source of revenue. The company became highly profitable since the start of the COVID-19 pandemic when its traditional Chinese medicine product Lianhua Qingwen gained national popularity.

Revenue share of Yiling Pharmaceutical Co., Ltd. in 2022, by product segment

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

April 2023

Region

China

Survey time period

2022

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical industry in Scandinavia "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical industry in Scandinavia

Pharmaceutical sales

8

Patents and clinical trials

6

Trade

5

Key players

6

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in HungaryHealthcare in PolandPharmaceutical industry in the UKPharmaceutical market in ItalyPharmaceutical industry in Europe
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.